References
- Kleyman TR. Renal physiology: an evolving field. Am J Physiol Renal Physiol. 2007;293(1):F1. doi: 10.1152/ajprenal.00189.2007
- GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi: 10.1016/S0140-6736(20)30045-3
- Ogedegbe HO. Renal function tests: a clinical laboratory perspective. Laboratory Medicine. 2007;38(5):295–304. doi: 10.1309/RWG5DY7RG1CYBUR7
- Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AA, Vernekar SN. Markers of renal function tests. N Am J Med Sci. 2010;2(4):170–173.
- Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–2483. doi: 10.1056/NEJMra054415
- Mouton R, Holder K. Laboratory tests of renal function. Anaesthesia & Intensive Care Medicine. 2006;7(7):240–243. doi: 10.1053/j.mpaic.2006.04.003
- Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141(12):929–937. doi: 10.7326/0003-4819-141-12-200412210-00009
- Rigalleau V, Lasseur C, Perlemoine C, et al. Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care. 2005;28(4):838–843. doi: 10.2337/diacare.28.4.838
- Hošková L, Franekova J, Málek I, et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. Ann Transplant. 2016;21:329–245. doi: 10.12659/aot.896700
- Himmelfarb J, Sayegh MH. Chronic kidney disease, dialysis, and transplantation. 3rd ed. Philadelphia: Saunders, 2010.
- Delinière A, Baranchuk A, Giai J, et al. Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogram. Europace. 2019;21(9):1400–1409. doi: 10.1093/europace/euz156
- Scridon A, Șerban RC. Laboratory monitoring – a turning point in the use of new oral anticoagulants. Ther Drug Monit. 2016;38(1):12–21. doi: 10.1097/FTD.0000000000000247
- Shacham Y, Leshem-Rubinow E, Steinvil A, et al. Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study. Clin Res Cardiol. 2014;103(7):525–532. doi: 10.1007/s00392-014-0680-8
- Endre ZH, Walker RJ. Biomarkers of cardiovascular risk in chronic kidney disease. In Biomarkers of Kidney Disease. 2nd ed. Cambridge, MA: Academic Press, 2017.
- Liu Z, Shang A, Chen Z, Yin L, Qi H. Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans. Medicine (Baltimore). 2020;99(37):e21386. doi: 10.1097/MD.0000000000021386
- Șerban RC, Șuș I, Lakatos EK, et al. Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Acta Cardiol. 2019;74(6):472–479. doi: 10.1080/00015385.2018.1521558
- Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem. 2002;48(5):699–707.
- Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013;207(4):663–672. doi: 10.1111/apha.12054
- Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012–1024. doi: 10.1053/j.ajkd.2009.07.020
- Lupu L, Abukatash H, Banai A, et al. Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients. J Clin Med. 2021;10(22):5403. doi: 10.3390/jcm10225403
- Murray PT, Mehta RL, Shaw A, et al; ADQI 10 workgroup. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014;85(3):513–521. doi: 10.1038/ki.2013.374
- Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem. 2002;48(6 Pt 1):850–858.
- Odden MC, Tager IB, Gansevoort RT, et al. Age and cystatin C in healthy adults: a collaborative study. Nephrol Dial Transplant. 2010;25(2):463–469. doi: 10.1093/ndt/gfp474
- Yndestad A, Landrø L, Ueland T, et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009;30(10):1229–1236. doi:10.1093/eurheartj/ehp088
- Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2006;2(2):80–91. doi: 10.1038/ncpneph0076
- Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. Am J Kidney Dis. 2018;71(3):362–370. doi: 10.1053/j.ajkd.2017.08.017
- Kurts C. A crystal-clear mechanism of chronic kidney disease. Kidney Int. 2013;84(5):859–861. doi: 10.1038/ki.2013.251
- Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269–275. doi: 10.1097/HJH.0b013e3282f240bf
- Muntner P, Vupputuri S, Coresh J, Uribarri J, Fox CS. Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int. 2009;76(1):81–88. doi: 10.1038/ki.2009.76
- Eriksson P, Deguchi H, Samnegård A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol. 2004;24(3):551–557. doi: 10.1161/01.ATV.0000117180.57731.36
- Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z. Lipid Accumulation and Chronic Kidney Disease. Nutrients. 2019;11(4):722. doi: 10.3390/nu11040722
- Hounkpatin HO, Fraser SDS, Glidewell L, Blakeman T, Lewington A, Roderick PJ. Predicting Risk of Recurrent Acute Kidney Injury: A Systematic Review. Nephron. 2019;142(2):83–90. doi: 10.1159/000497385